Weir M P, Bethell S S, Cleasby A, Campbell C J, Dennis R J, Dix C J, Finch H, Jhoti H, Mooney C J, Patel S, Tang C M, Ward M, Wonacott A J, Wharton C W
Glaxo Wellcome Medicines Research Centre, Stevenage, Hertfordshire, U.K.
Biochemistry. 1998 May 12;37(19):6645-57. doi: 10.1021/bi972499o.
High-throughput screening of methanolic extracts from the leaves of the plant Lantana camara identified potent inhibitors of human alpha-thrombin, which were shown to be 5,5-trans-fused cyclic lactone euphane triterpenes [O'Neill et al. (1998) J. Nat. Prod. (submitted for publication)]. Proflavin displacement studies showed the inhibitors to bind at the active site of alpha-thrombin and alpha-chymotrypsin. Kinetic analysis of alpha-thrombin showed tight-binding reversible competitive inhibition by both compounds, named GR133487 and GR133686, with respective kon values at pH 8.4 of 1.7 x 10(6) s-1 M-1 and 4.6 x 10(6) s-1 M-1. Electrospray ionization mass spectrometry of thrombin/inhibitor complexes showed the tight-bound species to be covalently attached, suggesting acyl-enzyme formation by reaction of the active-site Ser195 with the trans-lactone carbonyl. X-ray crystal structures of alpha-thrombin/GR133686 (3.0 A resolution) and alpha-thrombin/GR133487 (2.2 A resolution) complexes showed continuous electron density between Ser195 and the ring-opened lactone carbonyl, demonstrating acyl-enzyme formation. Turnover of inhibitor by alpha-thrombin was negligible and mass spectrometry of isolated complexes showed that reversal of inhibition occurs by reformation of the trans-lactone from the acyl-enzyme. The catalytic triad appears undisrupted and the inhibitor carbonyl occupies the oxyanion hole, suggesting the observed lack of turnover is due to exclusion of water for deacylation. The acyl-enzyme inhibitor hydroxyl is properly positioned for nucleophilic attack on the ester carbonyl and therefore relactonization; furthermore, the higher resolution structure of alpha-thrombin/GR133487 shows this hydroxyl to be effectively superimposable with the recently proposed deacylating water for peptide substrate hydrolysis [Wilmouth, R. C., et al. (1997) Nat. Struct.Biol. 4, 456-462], suggesting the alpha-thrombin/GR133487 complex may be a good model for this reaction.
对马缨丹植物叶片甲醇提取物进行的高通量筛选,鉴定出了人α-凝血酶的强效抑制剂,这些抑制剂被证明是5,5-反式稠合的环内酯大戟烷三萜类化合物[奥尼尔等人(1998年),《天然产物杂志》(已提交发表)]。原黄素置换研究表明,这些抑制剂结合在α-凝血酶和α-胰凝乳蛋白酶的活性位点。对α-凝血酶的动力学分析表明,两种名为GR133487和GR133686的化合物对其具有紧密结合的可逆竞争性抑制作用,在pH 8.4时,它们各自的结合速率常数分别为1.7×10⁶ s⁻¹ M⁻¹和4.6×10⁶ s⁻¹ M⁻¹。凝血酶/抑制剂复合物的电喷雾电离质谱显示,紧密结合的物质是共价连接的,这表明活性位点的Ser195与反式内酯羰基反应形成了酰基酶。α-凝血酶/GR133686(分辨率为3.0 Å)和α-凝血酶/GR133487(分辨率为2.2 Å)复合物的X射线晶体结构显示,Ser195与开环内酯羰基之间存在连续的电子密度,证明了酰基酶的形成。α-凝血酶对抑制剂的周转可忽略不计,对分离出的复合物进行质谱分析表明,抑制作用的逆转是由于酰基酶重新形成反式内酯所致。催化三联体似乎未被破坏,抑制剂羰基占据氧阴离子洞,这表明观察到的缺乏周转是由于脱酰作用时水被排除。酰基酶抑制剂的羟基位置合适,可对酯羰基进行亲核攻击,因此可发生再内酯化;此外,α-凝血酶/GR133487的更高分辨率结构显示,该羟基与最近提出的用于肽底物水解的脱酰水有效地重叠[威尔茅斯,R.C.等人(1997年),《自然结构生物学》4,456 - 462],这表明α-凝血酶/GR133487复合物可能是该反应的良好模型。